CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

BACKGROUND: Induction chemotherapy incorporating docetaxel, cisplatin and 5- fluorouracil before radiotherapy may improve the outcome of patients with advanced head and neck cancer. Nevertheless, the addition of docetaxel increases hematological toxicity and infectious complications. Therefore, gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Melchardt, Thomas, Hufnagl, Clemens, Magnes, Teresa, Weiss, Lukas, Hutarew, Georg, Neureiter, Daniel, Schlattau, Alexander, Moser, Gerhard, Gaggl, Alexander, Tränkenschuh, Wolfgang, Greil, Richard, Egle, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609094/
https://www.ncbi.nlm.nih.gov/pubmed/26475344
http://dx.doi.org/10.1186/s12885-015-1776-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609094/
https://www.ncbi.nlm.nih.gov/pubmed/26475344
http://dx.doi.org/10.1186/s12885-015-1776-x

Ejemplares similares